0

Explore original, structured summaries for research and education.

Research profile

BPC-157

Extensively Studied

BPC-157 is indexed as a Pentadecapeptide research entry. Its current evidence category is Extensively Studied, and published discussion commonly places it within Healing & Recovery, Longevity. This profile summarizes identifiers and literature signals; it does not provide treatment or dosing advice.

Healing & RecoveryLongevity

Identity

Molecular Data

Molecular weight
1,419.53 Da
Chain length
15 amino acids
Type
Pentadecapeptide
Reported half-life
<30 minutes
Amino-acid sequenceGly-Lys-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Literature map

Research indications

Wound Healing

  • Tendon Healingmost effective
  • Muscle Recoverymost effective
  • Angiogenesiseffective

Neurological

  • Neuroprotectionmoderate
  • Spinal Cord Injurymoderate
  • Peripheral Nervesmoderate

Gastrointestinal

  • Ulcer Protectionmost effective
  • Intestinal Repaireffective
  • Mucosal Healingeffective

Evidence-gated guidance

Dosing Protocols

No established human dosing protocol is recognized for this research entry. Animal, laboratory, community, or vendor regimens must not be converted into personal dosing instructions.

Dose
Not established on this profile
Frequency
Not established on this profile
Cycle
Not established on this profile
Storage
Follow the exact supplier or authorized product documentation; requirements vary by formulation
Open peptide calculator →

Combination risks

Interactions

Evidence status

No independently verified interaction table is available here for BPC-157. Interaction risk depends on identity, formulation, medicines, supplements, and health conditions.

Do not infer compatibility

Being listed beside another compound does not mean that combining them is safe or effective.

Evidence-informed overview

What to Expect

Evidence boundary

Research indications describe topics studied in the literature; they do not predict an individual outcome.

Clinical monitoring

Where an authorized medicinal use exists, expectations and monitoring should come from the current product label and treating clinician.

Risk overview

Side Effects & Safety

The safety profile of BPC-157 cannot be inferred from category or molecular identity alone. Research-only materials are not medicines and should not be used in humans.

Verification

Quality Checklist

  1. Confirm exact chemical identity, sequence, salt form, and concentration.
  2. Require a batch-specific certificate of analysis with named test methods and results.
  3. Check manufacturer, lot, expiry, tamper evidence, and documented chain of custody.
  4. For laboratory work requiring sterility, verify sterility and endotoxin testing separately from purity.

Clear answers

Frequently Asked Questions

Is BPC-157 approved for personal use?

This catalogue does not identify an authorized personal-use indication. Treat it as research information unless a current local regulator says otherwise.

Why is no dose listed?

A dose is shown only when it has been checked against a current authoritative prescribing label. Speculative or community regimens are intentionally excluded.

Do research indications prove effectiveness?

No. They organize literature topics and evidence signals; they are not treatment recommendations or guarantees.

Source trail

References

  1. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growthStaresinic, M., et al. · Journal of Orthopaedic Research · 2003
  2. Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157Staresinic, M., et al. · Journal of Orthopaedic Research · 2006
  3. Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in ratsPerovic, D., et al. · Journal of Orthopaedic Surgery and Research · 2019
  4. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing CytoprotectionPark, J.M., Lee, H.J., Sikiric, P., Hahm, K.B. · Current Pharmaceutical Design · 2020
  5. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulationHsieh, M.J., et al. · Journal of Molecular Medicine · 2017
  6. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various woundsXu, C., et al. · Regulatory Toxicology and Pharmacology · 2020
  7. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyLee, E., Walker, C., Ayadi, B. · Alternative Therapies in Health and Medicine · 2024
  8. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot StudyLee, E., Burgess, K. · Alternative Therapies in Health and Medicine · 2025

View the structural source profile ↗